Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan

被引:56
作者
Hirayama, Kouichi [1 ]
Kobayashi, Masaki [1 ]
Usui, Joichi [2 ]
Arimura, Yoshihiro [3 ]
Sugiyama, Hitoshi [4 ]
Nitta, Kosaku [5 ]
Muso, Eri [6 ]
Wada, Takashi [7 ]
Matsuo, Seiichi [8 ]
Yamagata, Kunihiro [2 ]
机构
[1] Tokyo Med Univ, Ibaraki Med Ctr, Dept Nephrol, Ami, Ibaraki, Japan
[2] Univ Tsukuba, Dept Nephrol, Fac Med, Tsukuba, Ibaraki, Japan
[3] Kyorin Univ, Sch Med, Dept Internal Med 1, Mitaka, Tokyo 181, Japan
[4] Okayama Univ, Grad Sch Med, Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Peritoneal Dialysis, Okayama, Japan
[5] Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Shinjuku Ku, Tokyo, Japan
[6] Kitano Hosp, Tazuke Kofukai Med Inst, Div Nephrol & Dialysis, Osaka, Japan
[7] Kanazawa Univ, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan
[8] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan
关键词
alveolar hemorrhage; ANCA-associated vasculitis; interstitial lung disease; mortality; ANCA-ASSOCIATED VASCULITIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; POLYANGIITIS CHURG-STRAUSS; OF-THE-LITERATURE; MICROSCOPIC POLYANGIITIS; ALVEOLAR HEMORRHAGE; CLINICAL-FEATURES; EOSINOPHILIC GRANULOMATOSIS; WEGENERS-GRANULOMATOSIS; INTERSTITIAL PNEUMONIA;
D O I
10.1093/ndt/gfu385
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Pulmonary involvement is one of the hallmark lesions of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) as well as rapidly progressive glomerulonephritis (RPGN). However, the pulmonary involvement of AAV patients seems to differ between Europe and Japan, as does the ANCA serotype. This retrospective and prospective multicenter cohort study collected the clinical data of the features and outcomes of 1772 RPGN patients treated from 1989 to 2007 in Japan. Based on this nationwide RPGN survey, we analyzed the cases of 1147 AAV patients. We found that 52.3% of the AAV patients had pulmonary involvements: 15.4% of the AAV patients had alveolar hemorrhage (AH), 26.2% had interstitial lung disease (ILD), 2.8% had bronchial asthma, 2.4% had pulmonary granuloma and 12.8% had a chest X-ray abnormality without AH, ILD or pulmonary granuloma. Patient survival was significantly different among the following six groups: the 5-year survival rate was 41.5% in the patients with AH, 50.2% in those with ILD, 67.9% in those with bronchial asthma, 62.5% in those with pulmonary granuloma, 55.8% in those with chest X-ray abnormality and 73.3% in those without pulmonary involvement. AH was one of the predictors of 1- and 5-year mortality for patient survival in AAV, and ILD was added as one of the predictors of 5-year mortality. In these AAV patients, not only AH but also ILD was frequently observed. AH was associated with the prognosis, but ILD was associated with the long-term prognosis of AAV.
引用
收藏
页码:i83 / i93
页数:11
相关论文
共 50 条
  • [31] Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission
    Muto, Reiko
    Inagaki, Koji
    Sato, Naokazu
    Sameshima, Tetsuro
    Nagakura, Yuka
    Baba, Satoshi
    Kato, Noritoshi
    Maruyama, Shoichi
    Akahori, Toshiyuki
    INTERNAL MEDICINE, 2020, 59 (24) : 3187 - 3193
  • [32] Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Alberici, Federico
    Martorana, Davide
    Vaglio, Augusto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i37 - i45
  • [33] Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
    Binda, Valentina
    Favi, Evaldo
    Calatroni, Marta
    Moroni, Gabriella
    MEDICINA-LITHUANIA, 2021, 57 (12):
  • [34] Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis
    Merkel, P. A.
    Cuthbertson, D. D.
    Hellmich, B.
    Hoffman, G. S.
    Jayne, D. R. W.
    Kallenberg, C. G. M.
    Krischer, J. P.
    Luqmani, R.
    Mahr, A. D.
    Matteson, E. L.
    Specks, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (01) : 103 - 106
  • [35] Improvement of Alveolar Hemorrhaging in an Elderly and Renally Impaired Patient with Relapsing Anti-neutrophil Cytoplasmic Autoantibody-associated Vasculitis by Single Infusion of Rituximab
    Oda, Keiko
    Ishikawa, Eiji
    Ito, Takayasu
    Mizoguchi, Shoko
    Hirabayashi, Yosuke
    Suzuki, Yasuo
    Haruki, Ayumi
    Fujimoto, Mika
    Murata, Tomohiro
    Katayama, Kan
    Onishi, Takahiro
    Ito, Masaaki
    INTERNAL MEDICINE, 2018, 57 (22) : 3267 - 3270
  • [36] Slo-Mo anti-neutrophil cytoplasmic antibody-associated renal vasculitis
    Avello, Alejandro
    Fernandez-Prado, Raul
    Santos-Sanchez-Rey, Begona
    Rojas-Rivera, Jorge
    Ortiz, Alberto
    CLINICAL KIDNEY JOURNAL, 2021, 14 (01) : 18 - 22
  • [37] Dermatologic Manifestations of Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis
    Solhjoo, Mandis
    Hojjati, Mehrnaz
    JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION, 2021, 13 (05) : 265 - 270
  • [38] Anti-neutrophil cytoplasmic antibody-associated systemic vasculitis: nature or nurture?
    Gatenby, P. A.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (04) : 351 - 359
  • [39] Pleuritis and Pericarditis in Antineutrophi Cytoplasmic Autoantibody-Associated Vasculitis
    Thompson, Gwen E.
    Bourne, Michael H., Jr.
    Moura, Marta Casal
    Baqir, Misbah
    Cartin-Ceba, Rodrigo
    Makol, Ashima
    Koster, Matthew J.
    Warrington, Kenneth J.
    Borah, Bijan J.
    Specks, Ulrich
    CHEST, 2021, 160 (02) : 572 - 581
  • [40] Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes
    Shi, Lei
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (11) : 1779 - 1788